Capricor Therapeutics (CAPR) Current Leases (2021 - 2026)
Capricor Therapeutics' (CAPR) quarterly Current Leases came in at $841135.0 in Q1 2026, little changed year-on-year from $842101.0 in Q1 2025, and up 315.63% quarter-over-quarter from $202376.0 in Q4 2025.
Capricor Therapeutics (CAPR) Current Leases (2021 - 2026) Analysis & Trends
Capricor Therapeutics' Current Leases history runs 6 years deep, the most recent figure standing at $841135.0 for Q1 2026.
- On a quarterly basis, Current Leases changed 0.11% year-over-year to $841135.0 in Q1 2026; TTM through Mar 2026 was $841135.0, a 0.11% change from a year earlier, with the FY2025 full-year figure at $202376.0, down 75.76% from the prior year.
- Current Leases rose to $841135.0 in Q1 2026 per CAPR's latest filing, from $202376.0 in the prior quarter.
- Across five years, Current Leases topped out at $849505.0 in Q2 2025 and bottomed at $120094.0 in Q3 2025.
- The 5-year median for Current Leases is $729567.0 (2023), against an average of $670896.8.
- Across the five-year window, Current Leases surged 63.31% in 2022 and plunged 85.24% in 2025, its largest moves.
- Year by year, Current Leases stood at $682039.0 in 2022, then gained by 9.83% to $749112.0 in 2023, then rose by 11.44% to $834799.0 in 2024, then slumped by 75.76% to $202376.0 in 2025, then soared by 315.63% to $841135.0 in 2026.
- Per Business Quant, the three latest CAPR Current Leases figures stand at $841135.0 (Q1 2026), $202376.0 (Q4 2025), and $120094.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Capricor Therapeutics | 457.86 Mn | 457.86 Mn | - | 841,135.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 841,135.00 |
| Dec 31, 2025 | 202,376.00 |
| Sep 30, 2025 | 120,094.00 |
| Jun 30, 2025 | 849,505.00 |
| Mar 31, 2025 | 842,101.00 |
| Dec 31, 2024 | 834,799.00 |
| Sep 30, 2024 | 813,634.00 |
| Jun 30, 2024 | 792,694.00 |
| Mar 31, 2024 | 771,506.00 |
| Dec 31, 2023 | 749,112.00 |
| Sep 30, 2023 | 729,567.00 |
| Jun 30, 2023 | 707,425.00 |
| Mar 31, 2023 | 693,652.00 |
| Dec 31, 2022 | 682,039.00 |
| Sep 30, 2022 | 697,561.00 |
| Jun 30, 2022 | 579,672.00 |
| Mar 31, 2022 | 498,374.00 |
| Dec 31, 2021 | 417,632.00 |